Sales & Marketing News | pharmaphorum

News

Lilly climbs on stellar GLP-1 drug sales gain

Eli Lilly is celebrating a massive 54% increase in its third-quarter revenues to $17.6 billion, driven by its medicines for diabetes and obesity.

News

FDA plan will cut testing requirements for biosimilars

The FDA has proposed a radical change to the regulatory requirements for bringing biosimilar medicines to market as a way to cut US drug prices.

News

Specialty meds lift GSK's outlook in Walmsley's swan song

Emma Walmsley's last set of financial results as GSK's chief executive has gone swimmingly, allowing the company to raise its 2025 forecasts.

News

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

News

Texas sues J&J, Kenvue over Tylenol autism claim

Texas has filed a lawsuit against J&J and Kenvue over the debunked claim that Tylenol causes autism, recently trumpeted by President Trump.

News

Novartis' new drugs outweigh Entresto decline in Q3

Now feeling the impact of generic competition on its top product Entresto in the US, Novartis is still looking for pipeline-building deals, says CEO.

Lilly climbs on stellar GLP-1 drug sales gain

FDA plan will cut testing requirements for biosimilars

Specialty meds lift GSK's outlook in Walmsley's swan song

Falling flu vaccine sales in US stall CSL's Seqirus spinout

Texas sues J&J, Kenvue over Tylenol autism claim

Novartis' new drugs outweigh Entresto decline in Q3

Lilly UK recruits ex-England cricketer as obesity champion

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks